
Applied Catalysis A: General (2019)
Update date:2022-08-11
Topics:
Ojelade, Opeyemi A.
Zaman, Sharif F.
Daous, Muhammad A.
Al-Zahrani, Abdulrahim A.
Malik
Driss, Hafedh
Shterk, Genrikh
Gascon
We report the compositional optimization of Pd:Zn/CeO2 catalysts prepared via sol-gel chelatization for the hydrogenation of CO2 under mild reaction conditions. The formation of a PdZn alloy, which is the main active phase for this reaction, was maximized for the catalyst with a Pd to Zn ratio close to 1. For this catalyst, a maximum conversion of 14%, close to thermodynamic equilibrium, and high selectivity to methanol (95%) were achieved at 220 °C, 20 bar, 2400 h?1 GHSV and H2:CO2 stoichiometric ratio of 3:1. The formation of PdZn alloys was achieved by reducing the catalyst precursor at 550 °C under hydrogen flow and confirmed by XRD. XPS study confirmed the presence of Pd°, being maximum for the optimized catalyst composition. At lower temperature, i.e. 180 °C, 1.0PdZn catalyst showed 100% selectivity to methanol with 8% CO2 conversion. RWGS reaction is responsible for the production of CO and its selectivity increases with temperature. In situ DRIFTS suggests that CO2 is activated as adsorbed CO3- species over CeO2. Surface micro-kinetics demonstrates that methanol can be formed either via formaldehyde or formic acid surface intermediates.
View More
Tai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Contact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
website:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Huludao Tianqi Shengye Chemical Co.,Ltd.
Contact:0086 429 2075777
Address:Area B,Shipbuilding Industry Park,Beigang District,Huludao City,Liaoning prov.,China
Doi:10.1016/S0040-4039(00)87720-5
(1982)Doi:10.1016/j.tet.2010.04.099
(2010)Doi:10.1016/S0020-1693(00)94060-X
(1976)Doi:10.1080/0049825021000017894
(2003)Doi:10.3390/pharmaceutics13050642
(2021)Doi:10.1007/s10600-013-0642-9
(2013)